Screening for hypoglycemia at the bedside in the neonatal intensive care unit (NICU) with the Abbott PCx glucose meter

<p>Abstract</p> <p>Background</p> <p>Point of care (POC) glucose meters are routinely used as a screening tool for hypoglycemia in a neonatal setting. Glucose meters however, lack the same accuracy as laboratory instruments for glucose measurement. In this study we inve...

Full description

Bibliographic Details
Main Authors: Ismaila Afisi, Grey Vijaylaxmi, Balion Cynthia, Blatz Susan, Seidlitz Wendy
Format: Article
Language:English
Published: BMC 2006-11-01
Series:BMC Pediatrics
Online Access:http://www.biomedcentral.com/1471-2431/6/28
id doaj-2842cf836f444d6a9e15f7122ac8fb24
record_format Article
spelling doaj-2842cf836f444d6a9e15f7122ac8fb242020-11-24T21:09:55ZengBMCBMC Pediatrics1471-24312006-11-01612810.1186/1471-2431-6-28Screening for hypoglycemia at the bedside in the neonatal intensive care unit (NICU) with the Abbott PCx glucose meterIsmaila AfisiGrey VijaylaxmiBalion CynthiaBlatz SusanSeidlitz Wendy<p>Abstract</p> <p>Background</p> <p>Point of care (POC) glucose meters are routinely used as a screening tool for hypoglycemia in a neonatal setting. Glucose meters however, lack the same accuracy as laboratory instruments for glucose measurement. In this study we investigated potential reasons for this inaccuracy and established a cut off value for confirmatory testing.</p> <p>Methods</p> <p>In this prospective study, all patients in the neonatal intensive care unit who had a plasma glucose test ordered were eligible to participate. Demographic information, sample collection information (nine variables) and a recent hematocrit value were recorded for each sample. Glucose measurements were taken at the bedside on the glucose meter (RN PCx) as well as in the laboratory on both the glucose meter (LAB PCx) and the laboratory analyzer (PG). Data were analyzed by simple and mixed-effects regression analysis and by analysis of a receiver operator characteristics (ROC) curve.</p> <p>Results</p> <p>There were 475 samples analyzed from 132 patients. RN PCx values were higher than PG values (mean = 4.9%), while LAB PCx results were lower (mean = -5.2%) than PG values. Only 31% of the difference between RN PCx – PG and 46% of the difference for LAB PCx – PG could be accounted for by the variables tested. The largest proportion of variance between PCx and PG measurements was explained by hematocrit (about 30%) with a greater effect seen at glucose concentrations ≤4.0 mmol/L (≤72 mg/dL)(48% and 40% for RN PCx and LAB PCx, respectively). The ROC analysis showed that for detection of all cases of hypoglycemia (PG < 2.6 mmol/L)(PG < 47 mg/dL) the PCx screening cut off value would need to be set at 3.8 mmol/L (68 mg/dL) requiring 20% of all samples to have confirmatory analysis by the laboratory method.</p> <p>Conclusion</p> <p>The large difference between glucose results obtained by PCx glucose meter compared to the laboratory analyzer can be explained in part by hematocrit and low glucose concentration. These results emphasize that the glucose meter is useful only as a screening device for neonatal hypoglycemia and that a screening cut off value must be established.</p> http://www.biomedcentral.com/1471-2431/6/28
collection DOAJ
language English
format Article
sources DOAJ
author Ismaila Afisi
Grey Vijaylaxmi
Balion Cynthia
Blatz Susan
Seidlitz Wendy
spellingShingle Ismaila Afisi
Grey Vijaylaxmi
Balion Cynthia
Blatz Susan
Seidlitz Wendy
Screening for hypoglycemia at the bedside in the neonatal intensive care unit (NICU) with the Abbott PCx glucose meter
BMC Pediatrics
author_facet Ismaila Afisi
Grey Vijaylaxmi
Balion Cynthia
Blatz Susan
Seidlitz Wendy
author_sort Ismaila Afisi
title Screening for hypoglycemia at the bedside in the neonatal intensive care unit (NICU) with the Abbott PCx glucose meter
title_short Screening for hypoglycemia at the bedside in the neonatal intensive care unit (NICU) with the Abbott PCx glucose meter
title_full Screening for hypoglycemia at the bedside in the neonatal intensive care unit (NICU) with the Abbott PCx glucose meter
title_fullStr Screening for hypoglycemia at the bedside in the neonatal intensive care unit (NICU) with the Abbott PCx glucose meter
title_full_unstemmed Screening for hypoglycemia at the bedside in the neonatal intensive care unit (NICU) with the Abbott PCx glucose meter
title_sort screening for hypoglycemia at the bedside in the neonatal intensive care unit (nicu) with the abbott pcx glucose meter
publisher BMC
series BMC Pediatrics
issn 1471-2431
publishDate 2006-11-01
description <p>Abstract</p> <p>Background</p> <p>Point of care (POC) glucose meters are routinely used as a screening tool for hypoglycemia in a neonatal setting. Glucose meters however, lack the same accuracy as laboratory instruments for glucose measurement. In this study we investigated potential reasons for this inaccuracy and established a cut off value for confirmatory testing.</p> <p>Methods</p> <p>In this prospective study, all patients in the neonatal intensive care unit who had a plasma glucose test ordered were eligible to participate. Demographic information, sample collection information (nine variables) and a recent hematocrit value were recorded for each sample. Glucose measurements were taken at the bedside on the glucose meter (RN PCx) as well as in the laboratory on both the glucose meter (LAB PCx) and the laboratory analyzer (PG). Data were analyzed by simple and mixed-effects regression analysis and by analysis of a receiver operator characteristics (ROC) curve.</p> <p>Results</p> <p>There were 475 samples analyzed from 132 patients. RN PCx values were higher than PG values (mean = 4.9%), while LAB PCx results were lower (mean = -5.2%) than PG values. Only 31% of the difference between RN PCx – PG and 46% of the difference for LAB PCx – PG could be accounted for by the variables tested. The largest proportion of variance between PCx and PG measurements was explained by hematocrit (about 30%) with a greater effect seen at glucose concentrations ≤4.0 mmol/L (≤72 mg/dL)(48% and 40% for RN PCx and LAB PCx, respectively). The ROC analysis showed that for detection of all cases of hypoglycemia (PG < 2.6 mmol/L)(PG < 47 mg/dL) the PCx screening cut off value would need to be set at 3.8 mmol/L (68 mg/dL) requiring 20% of all samples to have confirmatory analysis by the laboratory method.</p> <p>Conclusion</p> <p>The large difference between glucose results obtained by PCx glucose meter compared to the laboratory analyzer can be explained in part by hematocrit and low glucose concentration. These results emphasize that the glucose meter is useful only as a screening device for neonatal hypoglycemia and that a screening cut off value must be established.</p>
url http://www.biomedcentral.com/1471-2431/6/28
work_keys_str_mv AT ismailaafisi screeningforhypoglycemiaatthebedsideintheneonatalintensivecareunitnicuwiththeabbottpcxglucosemeter
AT greyvijaylaxmi screeningforhypoglycemiaatthebedsideintheneonatalintensivecareunitnicuwiththeabbottpcxglucosemeter
AT balioncynthia screeningforhypoglycemiaatthebedsideintheneonatalintensivecareunitnicuwiththeabbottpcxglucosemeter
AT blatzsusan screeningforhypoglycemiaatthebedsideintheneonatalintensivecareunitnicuwiththeabbottpcxglucosemeter
AT seidlitzwendy screeningforhypoglycemiaatthebedsideintheneonatalintensivecareunitnicuwiththeabbottpcxglucosemeter
_version_ 1716757082875625472